Aurora Cannabis Inc. (ACB.TO)
| Previous close | 0.6200 |
| Open | 0.6100 |
| Bid | 0.6300 x 0 |
| Ask | 0.6400 x 0 |
| Day's range | 0.6100 - 0.6400 |
| 52-week range | 0.5600 - 1.9900 |
| Volume | |
| Avg. volume | 3,075,860 |
| Market cap | 299.281M |
| Beta (5Y monthly) | 2.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results for the second quarter of fiscal year 2024. As the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for Q2 2024 ending September 30, 2023, is Q1 2023 ending September 30, 2022.
- PR Newswire
Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2024 on Thursday, November 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2024 after the close of markets that same day.
- PR Newswire
Aurora Cannabis Announces Settlement of Patent Litigation
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the company and WILLOW BIOSCIENCES, INC. ("Willow") have successfully completed a confidential settlement resolving the ongoing patent litigation between the two parties in Canada.
